A 24-year-old G2P1 at 28 weeks of gestation presents with regular uterine contractions (4 in 10 minutes) and mild vaginal spotting. She denies rupture of membranes. Vital signs are normal. Speculum examination shows a closed cervix with no active bleeding. Fetal heart rate is 140 bpm. Ultrasound confirms a singleton pregnancy with appropriate growth and amniotic fluid volume. Cervical length by transvaginal ultrasound is 2.8 cm. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has **threatened preterm labor** at 28 weeks (regular contractions, closed cervix, no ROM). The cervical length of 2.8 cm is borderline short but not severely shortened. Management requires both **tocolysis** and **corticosteroids**. ## Preterm Labor Management at 28 Weeks **Key Point:** At 28 weeks, the fetus has significant morbidity/mortality risk; aggressive intervention with tocolytics and corticosteroids is justified. Nifedipine is a first-line tocolytic agent. **High-Yield:** Tocolytic agents and their roles in preterm labor: | Agent | Mechanism | Efficacy | Side Effects | Notes | |-------|-----------|----------|--------------|-------| | **Nifedipine** (calcium channel blocker) | Inhibits uterine smooth muscle contraction | ↓ delivery <7 days; ↓ neonatal complications | Maternal hypotension, flushing, headache | **First-line** at most centers; oral loading then maintenance | | **Indomethacin** (NSAID) | ↓ prostaglandin synthesis | Effective <32 weeks | Oligohydramnios, PDA closure, NEC risk | Avoid >32 weeks; max 48 hours | | **Magnesium sulfate** | Stabilizes cell membranes; weak tocolytic | **Poor tocolytic efficacy** | Hypermagnesemia, respiratory depression | Use **only for neuroprotection** (≤32 weeks) | | **Terbutaline** (β~2~-agonist) | ↑ cAMP in smooth muscle | Effective but ↑ maternal tachycardia | Tachycardia, tremor, hyperglycemia | Avoid in cardiac disease; not preferred | **Mnemonic:** **MINT** = **M**agnesium (neuroprotection only), **I**ndomethacin (early PTL), **N**ifedipine (first-line), **T**erbutaline (avoid if possible) ## Why Nifedipine + Betamethasone? 1. **Nifedipine 20 mg PO** → repeat 20 mg at 30 min if contractions persist → then 10–20 mg PO q4–6h for maintenance - Delays delivery by ~7 days on average - Allows time for corticosteroid effect and in-utero transfer if needed - Oral route is convenient and well-tolerated 2. **Betamethasone 12 mg IM** (two doses, 24 hours apart) - Reduces RDS by ~50%, IVH by ~30%, neonatal death by ~30% [cite:ACOG Preterm Labor Guidelines] - Most effective between 24–34 weeks **Clinical Pearl:** Magnesium sulfate is NOT a tocolytic — it is used **only for neuroprotection** (reduces cerebral palsy risk by ~30%) in singleton pregnancies ≤32 weeks. It does NOT delay delivery and should NOT replace nifedipine or indomethacin for tocolysis. ## Management Flowchart ```mermaid flowchart TD A["Preterm labor 28 weeks"]:::outcome --> B{"Contraindications to tocolysis?"}:::decision B -->|Infection, abruption, fetal distress| C["Deliver"]:::urgent B -->|No| D["Start tocolytic"]:::action D --> E{"Gestational age?"}:::decision E -->|<32 weeks| F["Nifedipine OR indomethacin"]:::action E -->|≥32 weeks| G["Nifedipine preferred"]:::action F --> H["Add betamethasone"]:::action G --> H H --> I["Add magnesium sulfate for neuroprotection if <32 weeks"]:::action I --> J["Monitor for 48-72 hours"]:::action ``` ## Contraindications to Tocolytics - Maternal hemodynamic instability - Placental abruption - Chorioamnionitis - Fetal distress (non-reassuring FHR) - Maternal cardiac disease (relative for β-agonists) This patient has **none** of these, so tocolysis is appropriate.